INTRAVITREAL BEVACIZUMAB FOR THE TREATMENT OF VITREOUS HEMORRHAGE DUE TO PROLIFERATIVE DIABETIC RETINOPATHY

PURPOSE: To evaluate the outcomes of intravitreal bevacizumab (IVB) use in patients with a vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR). DESIGN: Retrospective, interventional case series. METHODS: Patients who presented to Scheie Eye Institute between January 2008 a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Ophthalmol
Main Authors: Parikh, Rupin N., Traband, Anastasia, Kolomeyer, Anton M., VanderBeek, Brian L., Kim, Benjamin J., Maguire, Albert M., Brucker, Alexander J.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5376507/
https://ncbi.nlm.nih.gov/pubmed/28130042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2017.01.010
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares